The Role of Human Leukocyte Antigen Alleles and Maternal Microchimerism in Very-Early-Onset Ulcerative Colitis in

Masanori Toda1, Keisuke Jimbo2, Mitsuyoshi Suzuki2

  • 1Department of Pediatrics, Juntendo University Graduate School of Medicine, Tokyo, Japan.

PubMed

Insights

Very-early-onset ulcerative colitis (VEO-UC) involves specific human leukocyte antigen (HLA) alleles and maternal microchimerism (MMc). These genetic and maternal immune factors contribute to VEO-UC pathogenesis in Japanese children.

Area of Science:

  • Immunology
  • Genetics
  • Gastroenterology

Background:

  • Very-early-onset ulcerative colitis (VEO-UC) is a severe form of inflammatory bowel disease presenting before age 6.
  • VEO-UC exhibits distinct genetic and immunological characteristics compared to typical pediatric UC.
  • Investigating human leukocyte antigen (HLA) alleles and maternal microchimerism (MMc) is crucial for understanding VEO-UC pathogenesis.

Purpose of the Study:

  • To examine the association of specific HLA alleles with VEO-UC in a Japanese population.
  • To investigate the presence and role of maternal microchimerism (MMc) in VEO-UC intestinal tissues.
  • To elucidate the interplay of genetic and maternal immune factors in VEO-UC development.

Main Methods:

  • Case-control study involving 27 VEO-UC patients.
  • Human leukocyte antigen (HLA) typing using polymerase chain reaction-sequence-specific oligonucleotide probing (PCR-SSOP).
  • Immunohistochemistry and fluorescence in situ hybridization to detect maternal microchimerism (MMc).

Main Results:

  • Prevalence of HLA-B52 and HLA-DR15 was higher in VEO-UC cases compared to the general Japanese population.
  • Maternal microchimerism (MMc) was detected in intestinal tissues of three VEO-UC patients.
  • Maternal HLA concordance with VEO-UC associated alleles suggested maternal immune involvement.

Conclusions:

  • VEO-UC shares genetic predispositions with adult UC, including associations with HLA-B52 and HLA-DR15.
  • Maternal immune contributions, evidenced by MMc, play a role in VEO-UC pathogenesis.
  • Further research is needed to develop targeted therapies for VEO-UC based on genetic and immunological mechanisms.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...